North Providence, RI, United States of America

Djuro Josic

This inventor holds 2 USPTO granted patents. Top assignee: Prothera Biologics, Inc.. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Djuro Josic. Retrieved from https://idiyas.com/inventor/djuro-josic-ye45hjkc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • North Providence, RI (US) (2011)
  • Houston, TX (US) (2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Djuro Josic: Innovator in Therapeutic Proteins

Introduction

Djuro Josic is a notable inventor based in North Providence, RI (US). He has made significant contributions to the field of therapeutic proteins, particularly through his innovative work on inter-alpha inhibitor proteins.

Latest Patents

Djuro Josic holds 2 patents related to the preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use. His inventions focus on the purification processes of these proteins and their applications in treating various human diseases, including sepsis, septic shock, rheumatoid arthritis, cancer, and infectious diseases.

Career Highlights

Currently, Djuro Josic is associated with Prothera Biologics, Inc., where he continues to advance his research and development efforts in the field of biologics. His work is pivotal in exploring new therapeutic avenues for critical health conditions.

Collaborations

Throughout his career, Djuro has collaborated with esteemed colleagues, including Yow-Pin Lim and Douglas C Hixson. These partnerships have enhanced the scope and impact of his research.

Conclusion

Djuro Josic's innovative work in therapeutic proteins exemplifies the vital role of inventors in advancing medical science. His contributions are paving the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…